SLG
MYOK

Stanley-Laman Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Stanley-Laman Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,266
Closed -$264K – 289
2019
Q2 		$264K Buy
+5,266
New +$256K 0.06% 237

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Stanley-Laman Group's MYOK Position: Q3 2019 in Review

Stanley-Laman Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 5,266 shares — an estimated $264K sold.

Stanley-Laman Group first reported a position in MYOK in Q2 2019 and held it in 1 quarter. The position peaked at $264K in Q2 2019. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • Stanley-Laman Group reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Stanley-Laman Group sold 5,266 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $264K.
  • Stanley-Laman Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Stanley-Laman Group's MyoKardia, Inc. Common Stock position peaked at $264K in Q2 2019.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Stanley-Laman Group's 13F filing for Q3 2019, filed 8 Nov 2019.